Primary study · included by 1 review
Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.
Ramachandran 2016 · Ramachandran Balaji, Jayavelu Subramani, Murhekar Kanchan, et al. · Toxicology reports · 2016
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.